Literature DB >> 18937296

Replication of a rare protective allele in the noradrenaline transporter gene and ADHD.

X Xu1, Z Hawi, K J Brookes, R Anney, M Bellgrove, B Franke, E Barry, W Chen, J Kuntsi, T Banaschewski, J Buitelaar, R Ebstein, M Fitzgerald, A Miranda, R D Oades, H Roeyers, A Rothenberger, J Sergeant, E Sonuga-Barke, H-C Steinhausen, S V Faraone, M Gill, P Asherson.   

Abstract

Replication is a key to resolving whether a reported genetic association represents a false positive finding or an actual genetic risk factor. In a previous study screening 51 candidate genes for association with ADHD in a multi-centre European sample (the IMAGE project), two single nucleotide polymorphisms (SNPs) within the norepinephrine transporter (SLC6A2) gene were found to be associated with attention deficit hyperactivity disorder (ADHD). The same SNP alleles were also reported to be associated with ADHD in a separate study from the Massachusetts General Hospital in the US. Using two independent samples of ADHD DSM-IV combined subtype trios we attempted to replicate the reported associations with SNPs rs11568324 and rs3785143 in SLC6A2. Significant association of the two markers was not observed in the two independent replication samples. However, across all four datasets the overall evidence of association with ADHD was significant (for SNP rs11568324 P = 0.0001; average odds ratio = 0.33; for SNP rs3785143 P = 0.008; average odds ratio = 1.3). The data were consistent for rs11568324, suggesting the existence of a rare allele conferring protection for ADHD within the SLC6A2 gene. Further investigations should focus on identifying the mechanisms underlying the protective effect. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18937296      PMCID: PMC2587507          DOI: 10.1002/ajmg.b.30872

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  11 in total

1.  Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test.

Authors:  Adele A Mitchell; David J Cutler; Aravinda Chakravarti
Journal:  Am J Hum Genet       Date:  2003-02-13       Impact factor: 11.025

2.  Phenotype studies of the DRD4 gene polymorphisms in ADHD: association with oppositional defiant disorder and positive family history.

Authors:  Aiveen Kirley; Naomi Lowe; Celine Mullins; Mary McCarron; Grainne Daly; Irwin Waldman; Michael Fitzgerald; Michael Gill; Ziarih Hawi
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2004-11-15       Impact factor: 3.568

3.  Support for association between ADHD and two candidate genes: NET1 and DRD1.

Authors:  Aaron J Bobb; Anjene M Addington; Ellen Sidransky; Michele C Gornick; Jason P Lerch; Deanna K Greenstein; Liv S Clasen; Wendy S Sharp; Gale Inoff-Germain; Fabienne Wavrant-De Vrièze; Mauricio Arcos-Burgos; Richard E Straub; John A Hardy; F Xavier Castellanos; Judith L Rapoport
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2005-04-05       Impact factor: 3.568

4.  A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder.

Authors:  Chun-Hyung Kim; Maureen K Hahn; Yoosook Joung; Susan L Anderson; Angela H Steele; Michelle S Mazei-Robinson; Ian Gizer; Martin H Teicher; Bruce M Cohen; David Robertson; Irwin D Waldman; Randy D Blakely; Kwang-Soo Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-04       Impact factor: 11.205

5.  Reaction time, inhibition, working memory and 'delay aversion' performance: genetic influences and their interpretation.

Authors:  Jonna Kuntsi; Hannah Rogers; Greer Swinard; Norbert Börger; Jaap van der Meere; Fruhling Rijsdijk; Philip Asherson
Journal:  Psychol Med       Date:  2006-08-02       Impact factor: 7.723

6.  Further evidence of association between two NET single-nucleotide polymorphisms with ADHD.

Authors:  J W Kim; J Biederman; C L McGrath; A E Doyle; E Mick; J Fagerness; S Purcell; J W Smoller; P Sklar; S V Faraone
Journal:  Mol Psychiatry       Date:  2007-09-18       Impact factor: 15.992

7.  Conduct disorder and hyperactivity: I. Separation of hyperactivity and antisocial conduct in British child psychiatric patients.

Authors:  E Taylor; R Schachar; G Thorley; M Wieselberg
Journal:  Br J Psychiatry       Date:  1986-12       Impact factor: 9.319

Review 8.  The Child and Adolescent Psychiatric Assessment (CAPA).

Authors:  A Angold; M Prendergast; A Cox; R Harrington; E Simonoff; M Rutter
Journal:  Psychol Med       Date:  1995-07       Impact factor: 7.723

9.  The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes.

Authors:  K Brookes; X Xu; W Chen; K Zhou; B Neale; N Lowe; R Anney; R Aneey; B Franke; M Gill; R Ebstein; J Buitelaar; P Sham; D Campbell; J Knight; P Andreou; M Altink; R Arnold; F Boer; C Buschgens; L Butler; H Christiansen; L Feldman; K Fleischman; E Fliers; R Howe-Forbes; A Goldfarb; A Heise; I Gabriëls; I Korn-Lubetzki; L Johansson; R Marco; S Medad; R Minderaa; F Mulas; U Müller; A Mulligan; K Rabin; N Rommelse; V Sethna; J Sorohan; H Uebel; L Psychogiou; A Weeks; R Barrett; I Craig; T Banaschewski; E Sonuga-Barke; J Eisenberg; J Kuntsi; I Manor; P McGuffin; A Miranda; R D Oades; R Plomin; H Roeyers; A Rothenberger; J Sergeant; H-C Steinhausen; E Taylor; M Thompson; S V Faraone; P Asherson
Journal:  Mol Psychiatry       Date:  2006-08-08       Impact factor: 15.992

10.  Estimation of significance thresholds for genomewide association scans.

Authors:  Frank Dudbridge; Arief Gusnanto
Journal:  Genet Epidemiol       Date:  2008-04       Impact factor: 2.135

View more
  13 in total

1.  Atomoxetine facilitates attentional set shifting in adolescent rats.

Authors:  Rachel E Cain; Michelle C Wasserman; Barry D Waterhouse; Jill A McGaughy
Journal:  Dev Cogn Neurosci       Date:  2011-10       Impact factor: 6.464

2.  Differential association between the norepinephrine transporter gene and ADHD: role of sex and subtype.

Authors:  Sarojini M Sengupta; Natalie Grizenko; Geeta A Thakur; Johanne Bellingham; Rosherrie DeGuzman; Sandra Robinson; Marina TerStepanian; Anna Poloskia; S M Shaheen; Marie-Eve Fortier; Zia Choudhry; Ridha Joober
Journal:  J Psychiatry Neurosci       Date:  2012-02       Impact factor: 6.186

3.  VMAT2 gene (SLC18A2) variants associated with a greater risk for developing opioid dependence.

Authors:  Matthew Randesi; Wim van den Brink; Orna Levran; Peter Blanken; Jan M van Ree; Jurg Ott; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2019-04-15       Impact factor: 2.533

Review 4.  Molecular genetics of attention-deficit/hyperactivity disorder: an overview.

Authors:  Tobias Banaschewski; Katja Becker; Susann Scherag; Barbara Franke; David Coghill
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-10       Impact factor: 4.785

5.  Novel and functional norepinephrine transporter protein variants identified in attention-deficit hyperactivity disorder.

Authors:  Maureen K Hahn; Angela Steele; R Steven Couch; Mark A Stein; Jessica J Krueger
Journal:  Neuropharmacology       Date:  2009-08-19       Impact factor: 5.250

6.  Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior.

Authors:  H M Fentress; R Klar; J J Krueger; T Sabb; S N Redmon; N M Wallace; J K Shirey-Rice; M K Hahn
Journal:  Genes Brain Behav       Date:  2013-10-09       Impact factor: 3.449

7.  Further evidence of association between amphetamine response and SLC6A2 gene variants.

Authors:  Andrea M Dlugos; Ajna Hamidovic; Abraham A Palmer; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2009-10       Impact factor: 4.530

8.  A genetic study of ADHD and activity level in infancy.

Authors:  N Ilott; K J Saudino; A Wood; P Asherson
Journal:  Genes Brain Behav       Date:  2009-12-17       Impact factor: 3.449

9.  Genetic influences on attention deficit hyperactivity disorder symptoms from age 2 to 3: a quantitative and molecular genetic investigation.

Authors:  Nicholas E Ilott; Kimberly J Saudino; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-12-01       Impact factor: 3.630

10.  Comprehensive phenotype/genotype analyses of the norepinephrine transporter gene (SLC6A2) in ADHD: relation to maternal smoking during pregnancy.

Authors:  Geeta A Thakur; Sarojini M Sengupta; Natalie Grizenko; Zia Choudhry; Ridha Joober
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.